138 related articles for article (PubMed ID: 12517441)
1. Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.
Yu D; Kandimalla ER; Zhao Q; Bhagat L; Cong Y; Agrawal S
Bioorg Med Chem; 2003 Feb; 11(3):459-64. PubMed ID: 12517441
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequences.
Yu D; Kandimalla ER; Cong Y; Tang J; Tang JY; Zhao Q; Agrawal S
J Med Chem; 2002 Sep; 45(20):4540-8. PubMed ID: 12238933
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immunostimulatory activity of CpG oligonucleotides by site-specific deletion of nucleobases.
Yu D; Kandimalla ER; Zhao Q; Cong Y; Agrawal S
Bioorg Med Chem Lett; 2001 Sep; 11(17):2263-7. PubMed ID: 11527711
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of ligands at the 5'-end of CpG DNA affects immunostimulatory activity.
Kandimalla ER; Bhagat L; Yu D; Cong Y; Tang J; Agrawal S
Bioconjug Chem; 2002; 13(5):966-74. PubMed ID: 12236778
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNA.
Agrawal S; Kandimalla ER
Ann N Y Acad Sci; 2003 Dec; 1002():30-42. PubMed ID: 14751820
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosphonate linkages.
Yu D; Kandimalla ER; Zhao Q; Cong Y; Agrawal S
Bioorg Med Chem; 2001 Nov; 9(11):2803-8. PubMed ID: 11597460
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory properties of phosphorothioate CpG DNA containing both 3'-5'- and 2'-5'-internucleotide linkages.
Yu D; Kandimalla ER; Zhao Q; Cong Y; Agrawal S
Nucleic Acids Res; 2002 Apr; 30(7):1613-9. PubMed ID: 11917022
[TBL] [Abstract][Full Text] [Related]
8. Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships.
Kandimalla ER; Yu D; Zhao Q; Agrawal S
Bioorg Med Chem; 2001 Mar; 9(3):807-13. PubMed ID: 11310616
[TBL] [Abstract][Full Text] [Related]
9. Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity.
Yu D; Zhao Q; Kandimalla ER; Agrawal S
Bioorg Med Chem Lett; 2000 Dec; 10(23):2585-8. PubMed ID: 11128629
[TBL] [Abstract][Full Text] [Related]
10. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.
Du HY; Xia SY; Song HF; Li N; Shang MM; Zou J; Wang QQ; Ou L; Sun X; Ji AG; Tang ZM
Acta Pharmacol Sin; 2007 Oct; 28(10):1637-44. PubMed ID: 17883951
[TBL] [Abstract][Full Text] [Related]
11. Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles.
Kandimalla ER; Bhagat L; Wang D; Yu D; Zhu FG; Tang J; Wang H; Huang P; Zhang R; Agrawal S
Nucleic Acids Res; 2003 May; 31(9):2393-400. PubMed ID: 12711684
[TBL] [Abstract][Full Text] [Related]
12. A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.
Kandimalla ER; Bhagat L; Zhu FG; Yu D; Cong YP; Wang D; Tang JX; Tang JY; Knetter CF; Lien E; Agrawal S
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14303-8. PubMed ID: 14610275
[TBL] [Abstract][Full Text] [Related]
13. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
[TBL] [Abstract][Full Text] [Related]
14. CpG oligonucleotides with modified termini and nicked dumbbell structure show enhanced immunostimulatory activity.
Narayanan S; Dalpke AH; Siegmund K; Heeg K; Richert C
J Med Chem; 2003 Nov; 46(23):5031-44. PubMed ID: 14584953
[TBL] [Abstract][Full Text] [Related]
15. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
Chaung HC
Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
[TBL] [Abstract][Full Text] [Related]
17. CpG motifs as immune adjuvants.
Klinman DM; Barnhart KM; Conover J
Vaccine; 1999 Jan; 17(1):19-25. PubMed ID: 10078603
[TBL] [Abstract][Full Text] [Related]
18. Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties.
Yu D; Zhu FG; Bhagat L; Wang H; Kandimalla ER; Zhang R; Agrawal S
Biochem Biophys Res Commun; 2002 Sep; 297(1):83-90. PubMed ID: 12220512
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory CpG oligonucleotides form defined three-dimensional structures: results from an NMR study.
He G; Patra A; Siegmund K; Peter M; Heeg K; Dalpke A; Richert C
ChemMedChem; 2007 Apr; 2(4):549-60. PubMed ID: 17366653
[TBL] [Abstract][Full Text] [Related]
20. Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity.
Zhao Q; Yu D; Agrawal S
Bioorg Med Chem Lett; 1999 Dec; 9(24):3453-8. PubMed ID: 10617090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
